Noninvasive assessment of pharmaceutical intervention during myocardial ischemia-reperfusion in a canine model using two-dimensional 31P chemical shift imaging

Biochemistry and Cell Biology

Volumn 76, Issue 2-3, 1998, Pages 522-531

  Campbell, Constance M ^a   Wisenberg, Gerald ^b   Sykes, Jane ^b   Thompson, R Terry ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Diltiazem; Magnetic resonance spectroscopy; Myocardial infarction; Propranolol

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIANGINA PECTORIS AGENT; CREATINE PHOSPHATE; DILTIAZEM; GADOLINIUM PENTETATE; MICROSPHERE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PH; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; HIGH ENERGY PHOSPHATE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; TISSUE NECROSIS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0032464265     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/bcb-76-2-3-522     Document Type: Article

References (40)

1. Bak, M.I., and Ingwall, J.S. 1994. Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. J. Clin. Invest. 93: 40-49.
2. Bing, R.D. 1961. Metabolic activity of the intact heart. Am. J. Med. 30: 679-691.
3. Bottomley, P.A. 1994. MR spectroscopy of the human heart: the status and the challenges. Radiology, 191: 593-612.
4. Bush, L.R., Romson, J.L., Ash, J.L., and Lucchesi, B.R. 1982. Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs. J. Cardiovasc. Pharmacol. 4: 285-296.
5. Camacho, S.A., and Schaefer, S. 1993. Magnetic resonance spectroscopy of myocardial ischemia. In Cardiovascular magnetic resonance spectroscopy. Edited by S. Schaefer and R.S. Balaban. Academic Press, Boston. pp. 111-125.
6. 31P chemical shift spectroscopic imaging. Am. Heart J. 133: 508-516.
7. Dendale, P.A.C., Franken, P.R., Waldman, G., Moor, D.G., Tombeur, D.A., Block, P.F., and DeRoos, A. 1995. Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am. Heart J. 130: 134-140.
8. De Roos, A., and van der Wall, E.E. 1994. Evaluation of ischemic heart disease by magnetic resonance imaging and spectroscopy. Radiol. Clin. North Am. 32: 581-592.
9. 31P NMR studies. Mol. Cell. Biochem. 176: 257-264.
10. Dole, W.P., Jackson, D.L., Rosenblatt, J.I., and Thompson, W.L. 1982. Relative error and variability in blood flow measurements with radiolabeled microspheres. Am. J. Physiol. 243: H371-H378.
11. 31P chemical shift spectroscopic imaging in a canine model. Magn. Reson. Med. 38: 577-584.
12. Flaherty, J.T., Weisfeldt, M.L., Buckley, B.H., Gardner, T.J., Gott, V.L., and Jacobus, W.E. 1982. Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation, 65: 561-570.
13. Franklin, D., Millard, R.W., and Nagao, T. 1980. Responses of coronary collateral flow and dependent myocardial mechanical function to the calcium antagonist, diltiazem. Chest 87(Suppl.): 200-204.
14. Jennings, R.B., Hawkins, H.K., Lowe, J.E., Hill, M.L., Klotman, S., and Reimer, K.A 1978. Relation between high energy phosphates and lethal injury in myocardial ischemia in the dog. Am. J. Pathol. 92: 187-214.
15. Jones, C.E., Thomas, J.X., Parker, J.C., and Parker, A.C. 1976. Acute changes in high energy phosphates: nucleotide derivatives and contractile force in ischemia and non-ischemic canine myocardium following coronary occlusion. Cardiovasc. Res. 10: 276-282.
16. Karmazyn, M. 1991. The 1990 Merck Frosst award. Ischemic and reperfusion injury in the heart. Cellular mechanisms and pharmacological interventions. Can. J. Physiol. Pharmacol. 69: 719-730.
17. Karmazyn, M., and Moffat, M.P. 1993. Role of Na+/ H+ exchange in cardiac physiology: mediation of myocardial reperfusion injury by the pH paradox (review). Cardiovasc. Res. 27: 915-924.
18. Katz, L.A., Swain, J.A., and Potrman, P.A. 1989. Relation between phosphate metabolites and oxygen consumption of the heart in vivo. Am. J. Physiol. 256: H265-H274.
19. 31P NMR study in isolated pig hearts. J. Mol. Cell. Cardiol. 27: 2237-2248.
20. Malloy, C.R., Mathews, P.M., Smith, M.B., and Radda, G.K. 1986. Influences of propranolol on acidosis and high energy phosphates in ischaemic myocardium of the rabbit. Cardiovasc. Res. 20: 710-720.
21. Nakamura, M., Koiwaya, Y., Yamada, A., KiKuchi, Y., Senda, Y., Ikeo, T., Sunagawa, K., Mori, M., and Kanaide, H. 1979. Effects of diltiazem, a new antianginal drug, following experimental coronary occlusion. In Ischemic myocardium and antianginal drugs. Edited by M.M. Winburg and Y. Abiko. Raven Press, New York. pp. 129-142.
22. Nejima, J., Knight, D.R., Fallon, J.T., Uemura, N., Manders, W.T., Canfield, D.R., Cohen, M.V., and Vatner, S.F. 1989. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function in myocardium at risk in conscious dogs. Circulation, 79: 143-153.
23. Neurohr, K.J., and Shulman, R.G. 1985. Carbon 13 and phosphorus 31 nuclear magnetic resonance studies of myocardial metabolism in live guinea pigs. Adv. Myocardiol. 6: 185-193.
24. Ochi, S., Ogawa, Y., Imai, H., Nakazawa, M., and Imai, S. 1988. Effects of β-blockers on the fall of pH in the early phase of ischemia in the isolated perfused rat heart: a nuclear magnetic resonance study. J. Cardiovasc. Pharmacol. 11: 326-331.
25. Pennell, D.J., Underwood, S.R., Manzara, C.C., Swanton, R.H., Walker, J.M., Ell, P.J., and Longmore, D.B. 1992. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am. J. Cardiol. 70: 34-40.
26. Periera, R., Prato, F.S., Wisenberg, G., and Sykes, J. 1996. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn. Reson. Med. 36: 684-693.
27. 31P nuclear magnetic resonance. Cardiovasc. Res. 14: 646-653.
28. Rehr, R.B., Fuhs, B.E., and Lee, F. 1991. Differentiation of reperfused-viable (stunned) from reperfused-infarcted myocardium at 1 to 3 days post reperfusion by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Am Heart J. 122: 1571-1582.
29. Rehr, R.B., Tatum, J.C., Hirsch, J.I., Quint, R., and Clarke, G. 1989. Reperfused-viable and reperfused-infarcted myocardium: differentiation with in vivo P-31 MR spectroscopy. Radiology, 172: 53-58.
30. Robb, R.A. 1990. A software system for interactive and quantitative analysis of biomedical images in 3D imaging in medicine. In NATO ASI series vF. No. 60. Edited by K.H. Hne, H. Fucks, and S.H. Pizer. Springer-Verlag, Berlin, Germany. pp. 333-361.
31. Rousseau, G., St-Jean, G., Lantour, J., Merhi, Y., Nattel, S., and Waters, D. 1991. Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium. Cardiovasc. Res. 25: 319-329.
32. Sack, S., Mohri, M., Schwarz, E.R., Arras, M., Schaper, J., Ballagi-Pordamy, G., Scholz, W., Scholkens, B.A., and Schaper, W. 1994. Effects of a new Na+/H+ antiporter inhibitor on postischemic reperfusion in pig heart. J. Cardiovasc. Pharmacol. 23: 72-78.
33. Schussheim, A.E., and Kantor, H.L. 1993. Cardiac nuclear magnetic resonance spectroscopy: investigations of physiology and diagnostic techniques. Coron. Artery Dis. 4: 361-369.
34. 1H MR spectra. Magn. Reson. Med. 34: 17-24.
35. Vanoverschelde, J.J., Janvier, M.F., Bakke, J.E., Marshall, D.R., and Bergmann, S.R. 1994. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am. J. Physiol. 267: H1785-H1794.
36. van Rugge, F.P., Van der Wall, E.E., de Roos, A., and Bruschke, A.V. 1993. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J. Am. Coll. Cardiol. 22: 431-439.
37. van Rugge, F.P., van der Wall, E.E., Spanjersberg, S.J., de Roos, A., Matheijssen, N.A., and Zwinderman, A.H. 1994. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Circulation, 90: 127-138.
38. Wilke, N., Simm, C., Zhang, J., Ellermann, J., Ya, X., Merkle, H., Path, G., Ludemann, H., Bache, R.J., and Ugurbil, K. 1993. Contrast-enhanced first pass myocardial perfusion imaging correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn. Reson. Med. 29: 485-497.
39. 31P nuclear magnetic resonance. Surgery, 97: 428-435.
40. 31P Nuclear magnetic resonance and ventricular function following graded cardiac ischemia. Curr. Surg. 41: 90-91.